Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells.

Source:http://linkedlifedata.com/resource/pubmed/id/21251202

Download in:

View as

Triples

General Info

PMID
21251202